miércoles, 8 de enero de 2025

FDA Approvals Expand Initial Treatment Options for Multiple Myeloma

https://www.cancer.gov/news-events/cancer-currents-blog/2025/fda-daratumumab-isatuximab-newly-diagnosed-myeloma?cid=eb_govdel

No hay comentarios:

Publicar un comentario